You are here

New treatment for reduced female libido

24-August-2015

Flibanserin, a new molecular entity, manufactured by Sprout Pharmaceuticals, which will be marketed under the brand name Addyi, has been approved by the FDA to treat premenopausal women with low sexual desire.

E-Alert

Subscribe to our E-Alert to stay informed of all new content as it's published on this platform.


Share


News

Commentaries by Editor Prof. Jim Thornton